Table 1.
The patient demographic data and the dose of insulin for 101 type 1 diabetic patients on basal-bolus insulin therapy as stratified equally by HbA1c value
| HbA1c | Group A HbA1c ≤7.2 % |
Group B 7.2 % <HbA1c ≤8.2 % |
Group C 8.2 % <HbA1c ≤9.2 % |
Group D HbA1c >9.2 % |
P value |
|---|---|---|---|---|---|
| Males /femalesa |
5/19 | 8/18 | 10/17 | 9/15 | 0.518 |
| Age (years)b |
36.5 (32.0–58.8) |
41.5 (31.5–54.5) |
41.0 (32.0–55.0) |
42.0 (35.0–57.8) |
0.956 |
| Duration of diabetes (years)b |
11.0 (5.3–30.0) |
15.0 (7.8–25.5) |
15.0 (5.0–24.0) |
10.5 (7.3–15.0) |
0.653 |
| BMI (kg/m2)b |
20.3 (18.2–22.3) |
22.6 (21.0–24.9) |
22.4 (20.0–23.8) |
22.2 (20.3–25.3) |
0.007 |
| U-CPR (µg/day)b |
1.2 (0.9–3.9) |
0.9 (0.6–2.6) |
1.3 (0.7–3.6) |
1.0 (0.5–6.0) |
0.622 |
| Total daily dose of insulin (units)b | 31.0 (25.5–38.8) |
35.0 (26.5–41.5) |
37.0 (29.0–46.0) |
39.0 (31.3–51.5) |
0.099 |
| Basal insulin dose (units)b | 13.5 (9.3–19.5) |
14.0 (10.0–20.3) |
15.0 (12.0–18.0) |
18.5 (14.0–24.8) |
0.021 |
| Bolus insulin dose (units)b | 17.0 (15.0–24.0) |
19.5 (15.0–24.3) |
20.0 (16.0–30.0) |
21.5 (13.8–27.5) |
0.296 |
Data presented as median (25–75 percentiles)
Italic values indicate significance of P value (P < 0.05)
aChi square test
bKruskal–Wallis test